查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1529649

核磁共振波谱市场规模、份额、趋势分析报告：2024-2030 年按类型、产品、最终用途、地区和细分市场预测

Nuclear Magnetic Resonance Spectroscopy Market Size, Share & Trends Analysis Report By Type (Low-field, High-field), By Products (Instruments, Consumables), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

核磁共振波谱市场成长与趋势：

Grand View Research, Inc.的最新报告显示，到2030年，全球核磁共振波谱市场规模预计将达到10.8亿美元。

预计2024年至2030年该市场将以5.1%的复合年增长率扩张。由于对代谢体学特异性诊断的需求不断增长，加上各领域的使用量增加，预计该市场将快速成长。布鲁克为多组体学、组织 SpatialOMx、蛋白质组学、功能结构生物学、生物分子缩合、生物製药和应用提供核磁共振 (NMR) 光谱解决方案。

核磁共振波谱市场预计将在 2021 年逐步成长，并在预测期内表现出类似的趋势。学术和大学研究中心对设备的需求对收益贡献很大。例如，2021 年 6 月，美国国家科学基金会宣布投资 4000 万美元，用于开发乔治亚大学、康涅狄格大学医学院和威斯康星大学麦迪逊分校国家磁共振设施之间的高级核磁共振网络 (NAN)。过。

其他决定因素，例如对学名药的需求快速增长、医疗保健技术进步、政府倡议和核磁共振波谱行业的津贴也促进了市场的成长。在美国，政府资助的-S10仪器计划已经建立，以协助购买设备，包括核磁共振波谱仪。目前有三个活跃的财政援助计划，截止日期为 2023 年 6 月。这些计划的金额从 25,000 美元到 2,000,000 美元不等。

COVID-19 的爆发预计将对该产品的需求产生积极影响。然而，供不应求和原物料价格上涨影响了参与企业的盈利。过去十年来，超导体中使用的关键原料（例如铜、铁和金属）的价格不断上涨。

癌症诊断需求的不断增长预计将在未来几年显着推动市场成长。正在使用核磁共振波谱研究帕金森氏症、癌症、感染疾病和精神疾病的诊断。例如，2022 年 1 月，牛津大学进行了研究，开发一种新的血液测试，可以利用 NMR代谢体学识别各种癌症。

另一方面，这是一个利基市场，参与企业有限。此外，核磁共振波谱被认为体积庞大且昂贵，400 MHz 的核磁共振波谱花费数十万美元，高场磁铁花费数百万美元。此外，需要定期填充低温流体的高场磁体，并且需要定期维护电子设备和探头，这增加了成本。

核磁共振波谱市场报告亮点

  • 从产品来看，由于大学和研究中心对高场核磁共振波谱的需求不断增加，设备领域在核磁共振波谱产业中占据了压倒性的份额。
  • 产品范围的稳步扩大正在对市场产生重大影响。例如，固体核磁共振波谱 (SSNMR) 被认为是药物表征的分析工具，从而推动了市场成长。
  • 按类型划分，高场核磁共振波谱细分市场将在 2023 年占据主导地位。
  • 按最终用途划分，2023 年学术领域占据主要份额。许多大学已采用核磁共振分析来增强製药和化学工业中化学品的鑑定。
  • 由于拥有大量大学以及政府为加强研究基础设施提供的资金不断增加，到 2023 年，北美将在全球市场中占据主要份额。
  • 由于原材料供应的增加以及製药和生物技术行业生物医学研究的增加，预计亚太地区未来将显着增长。

目录

第一章调查方法和范围

第二章执行概述

第三章核磁共振波谱市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 核磁共振波谱市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 核磁共振波谱市场的主要相关人员

第四章核磁共振波谱市场：产品估算与趋势分析

  • 全球核磁共振波谱市场：产品、仪表板
  • 全球核磁共振波谱市场：产品变异分析
  • 全球核磁共振波谱市场：依产品、按收益
  • 装置
  • 消耗品

第五章核磁共振波谱市场：类型、估计和趋势分析

  • 全球核磁共振波谱市场：类型仪表板
  • 全球核磁共振波谱市场：类型变异分析
  • 全球核磁共振波谱市场：按类型、按收益
  • 低场核磁共振波谱
  • 高场核磁共振波谱

第六章核磁共振波谱市场：最终应用、估计与趋势分析

  • 全球核磁共振波谱市场：最终用途仪表板
  • 全球核磁共振波谱市场：最终用途变化分析
  • 全球核磁共振波谱市场：依最终用途、按收益
  • 学术的
  • 製药和生物技术公司
  • 农业和食品
  • 化工
  • 其他的

第七章核磁共振波谱市场：按类型、产品、应用和最终用途的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 2023年主要企业市场占有率分析
    • JEOL Ltd.
    • Thermo Fisher Scientific Inc.
    • Bruker
    • Magritek
    • Oxford Instruments
    • Nanalysis Corp.
    • Anasazi Instruments, Inc.
    • QOneTec
    • Advanced Magnetic Resonance Limited
Product Code: GVR-4-68039-963-1

Nuclear Magnetic Resonance Spectroscopy Market Growth & Trends:

The global nuclear magnetic resonance spectroscopy market size is expected to reach USD 1.08 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 5.1% from 2024 to 2030. The rising need for metabolomics-based diagnosis, coupled with increasing usage in various fields, is anticipated to surge the growth of the market. Bruker offers nuclear magnetic resonance (NMR) spectroscopy solutions for multi-omics, tissue SpatialOMx, proteomics, functional structural biology, biomolecular condensates, and biopharma and applied.

The market for NMR spectroscopy witnessed incremental growth in 2021 and is anticipated to showcase a similar trend in the forecast period. The instrument demand from academic and university research centers is a significant contributor to the revenue. For instance, in June 2021, National Science Foundation announced an investment of USD 40 million to develop the Network for Advanced NMR (NAN) between the University of Georgia, UConn School of Medicine, and UW-Madison's National Magnetic Resonance Facility at Madison.

Other determinants such as the rapidly expanding demand for generic medicine, technical improvements in healthcare, as well as government initiatives and grants in the nuclear magnetic resonance spectroscopy industry are also contributing to the market's growth. In the U.S., government-funded - S10 Instrumentation Programs have been formed to support the purchase of instruments, including NMR spectroscopy. There are three active funding programs with June 2023 as the deadline. These programs range from USD 25,000 to USD 2,000,000.

The COVID-19 pandemic is anticipated to positively impact the demand for the product. However, supply shortages and accelerated prices of raw materials impacted the profitability of the players. The prices of key raw materials such as copper, steel, and metallic, used for superconductors, have risen over the last decade.

The increasing demand for cancer diagnostics is expected to majorly drive market growth in the coming years. Diagnosis for Parkinson's disease, cancer, infectious diseases, and psychiatric disorders, has been investigated with the use of NMR spectroscopy. For instance, in January 2022, a study was conducted at the University of Oxford to develop a new blood test, through NMR metabolomics, that can identify a range of cancers.

On the other hand, this is a niche market with limited players. Additionally, NMR spectroscopy is considered to be bulky and expensive, as its cost ranges from around a few hundred thousand dollars for 400 MHz, to millions for higher field magnets. Additionally, the requirement of high-field magnets, filled with cryogenic fluids regularly, and routine maintenance of electronics and probes increases the cost.

Nuclear Magnetic Resonance Spectroscopy Market Report Highlights:

  • By product, the instruments segment held the dominant share of the NMR spectroscopy industry, owing to the increasing demand by universities and research centers for high-field NMR spectroscopy
  • The steadily increasing scope of the product has a significant impact on the market. For instance, solid-state NMR spectroscopy (SSNMR) is considered an analytical tool for drug characterization, hence propelling the market growth
  • By type, the high-field NMR spectroscopy segment dominated the market in 2023, since it offers better sensitivity to the researchers
  • By end-use, the academic segment held a larger share in 2023; numerous universities employ NMR analysis to enhance chemical identification in pharmaceutical and chemical industries
  • North America held a substantial share in the global market in 2023 due to the presence of a large number of universities and increasing funding support by the government to enhance research infrastructure
  • The Asia Pacific region is projected to grow considerably in the future, owing to the rising availability of raw materials and increasing biomedical research in the pharma and biotech industry

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product and type outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Nuclear Magnetic Resonance Spectroscopy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Development Of Generic Drugs / API
      • 3.2.1.2. Acceleration In Biomedical Research
      • 3.2.1.3. Increasing Metabolomics-Based Diagnosis
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Expensive Equipment And Maintenance At Low Sensitivity
      • 3.2.2.2. The Presence Of Interfering Substances Disrupts The Research
  • 3.3. Nuclear Magnetic Resonance Spectroscopy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Key Stakeholders in the NMR Spectroscopy Market

Chapter 4. Nuclear Magnetic Resonance Spectroscopy Market: Product Estimates & Trend Analysis

  • 4.1. Global Nuclear Magnetic Resonance Spectroscopy Market: Product Dashboard
  • 4.2. Global Nuclear Magnetic Resonance Spectroscopy Market: Product Movement Analysis
  • 4.3. Global Nuclear Magnetic Resonance Spectroscopy Market by Product, Revenue
  • 4.4. Instruments
    • 4.4.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Consumables market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Nuclear Magnetic Resonance Spectroscopy Market: Type Estimates & Trend Analysis

  • 5.1. Global Nuclear Magnetic Resonance Spectroscopy Market: Type Dashboard
  • 5.2. Global Nuclear Magnetic Resonance Spectroscopy Market: Type Movement Analysis
  • 5.3. Global Nuclear Magnetic Resonance Spectroscopy Market by Type, Revenue
  • 5.4. Low-field NMR Spectroscopy
    • 5.4.1. Low-field NMR spectroscopy market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. High-field NMR spectroscopy
    • 5.5.1. High-field NMR Spectroscopy market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Nuclear Magnetic Resonance Spectroscopy Market: End Use Estimates & Trend Analysis

  • 6.1. Global Nuclear Magnetic Resonance Spectroscopy Market: End Use Dashboard
  • 6.2. Global Nuclear Magnetic Resonance Spectroscopy Market: End Use Movement Analysis
  • 6.3. Global Nuclear Magnetic Resonance Spectroscopy Market by End Use, Revenue
  • 6.4. Academic
    • 6.4.1. Academic market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Pharmaceutical and Biotech Companies
    • 6.5.1. Pharmaceutical and biotech companies market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Agriculture and Food
    • 6.6.1. Agriculture and food market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. Chemical Industry
    • 6.7.1. Chemical industry market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Nuclear Magnetic Resonance Spectroscopy Market: Regional Estimates & Trend Analysis by Type, Tube Material, Application, and End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 - 2030
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.4. South Korea
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.6. Singapore
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Singapore market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. JEOL Ltd.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Thermo Fisher Scientific Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Bruker
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Magritek
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Oxford Instruments
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Nanalysis Corp.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Anasazi Instruments, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. QOneTec
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Advanced Magnetic Resonance Limited
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 5 Global Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Global Nuclear Magnetic Resonance Spectroscopy, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 9 North America Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 10 North America Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 12 U.S. Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 15 Canada Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 16 Canada Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Europe Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 19 Europe Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 20 Europe Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Germany Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 22 Germany Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 23 Germany Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 24 UK Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 25 UK Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 26 UK Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 27 France Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 28 France Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 29 France Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 30 Italy Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 31 Italy Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 32 Italy Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Spain Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 34 Spain Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 35 Spain Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Denmark Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 37 Denmark Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 38 Denmark Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Sweden Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 40 Sweden Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 41 Sweden Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Norway Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 43 Norway Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 44 Norway Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 49 China Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 50 China Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 51 China Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 52 Japan Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 53 Japan Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 54 Japan Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 55 India Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 56 India Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 57 India Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 58 South Korea Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 59 South Korea Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 60 South Korea Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Australia Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 62 Australia Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 63 Australia Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Singapore Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 65 Singapore Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 66 Singapore Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 68 Thailand Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 69 Thailand Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 72 Latin America Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 73 Latin America Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 75 Brazil Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 76 Brazil Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Mexico Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 78 Mexico Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 79 Mexico Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Argentina Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 81 Argentina Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 82 Argentina Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 85 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 86 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 87 South Africa Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 88 South Africa Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 89 South Africa Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 93 UAE Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 94 UAE Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 95 UAE Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
  • Table 97 Kuwait Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
  • Table 98 Kuwait Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Nuclear Magnetic Resonance Spectroscopy Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Nuclear Magnetic Resonance Spectroscopy Market: Product Movement Analysis
  • Fig. 16 Global Nuclear Magnetic Resonance Spectroscopy Market, for Instruments, 2018 - 2030 (USD Million)
  • Fig. 17 Global Nuclear Magnetic Resonance Spectroscopy Market, for Consumables, 2018 - 2030 (USD Million)
  • Fig. 18 Global Nuclear Magnetic Resonance Spectroscopy Market: Type Movement Analysis
  • Fig. 19 Global Nuclear Magnetic Resonance Spectroscopy Market, for Low-field NMR Spectroscopy, 2018 - 2030 (USD Million)
  • Fig. 20 Global Nuclear Magnetic Resonance Spectroscopy Market, for High-field NMR Spectroscopy, 2018 - 2030 (USD Million)
  • Fig. 21 Global Nuclear Magnetic Resonance Spectroscopy Market: End-use Movement Analysis
  • Fig. 22 Global Nuclear Magnetic Resonance Spectroscopy Market, for Academic, 2018 - 2030 (USD Million)
  • Fig. 23 Global Nuclear Magnetic Resonance Spectroscopy Market, for Pharmaceutical and Biotech Companies, 2018 - 2030 (USD Million)
  • Fig. 24 Global Nuclear Magnetic Resonance Spectroscopy Market, for Agriculture and Food, 2018 - 2030 (USD Million)
  • Fig. 25 Global Nuclear Magnetic Resonance Spectroscopy Market, for Chemical Industry, 2018 - 2030 (USD Million)
  • Fig. 26 Global Nuclear Magnetic Resonance Spectroscopy Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 27 Regional Marketplace: Key Takeaways
  • Fig. 28 Regional Outlook, 2023 & 2030
  • Fig. 29 Global Nuclear Magnetic Resonance Spectroscopy Market: Region Movement Analysis
  • Fig. 30 North America Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 33 Europe Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 34 Germany Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 35 UK Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 36 France Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 37 Italy Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 38 Spain Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 39 Denmark Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 41 Norway Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 43 Japan Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 44 China Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 45 India Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 46 Australia Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 48 Singapore Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)